Back to Results
First PageMeta Content
Oral and maxillofacial surgery / Oral surgery / Otolaryngology / Restylane / Hyaluronan / Pharmacia / Vesicoureteral reflux / Macrolane / Bengt / Medicine / Glycosaminoglycans / Surgery


Document Date: 2011-12-15 01:58:53

Open Document

File Size: 229,14 KB

Share Result on Facebook

Company

Bengt Ågerup / Stockholm Stock Exchange / Pharmacia / 1999 Q-Med AB / Q-Med AB / Genzyme / Biomatrix Sv / /

Continent

Europe / /

Country

United States / Brazil / Canada / Sweden / /

Currency

SEK / /

Event

Employment Change / FDA Phase / /

Facility

Uppsala University / The University Hospital / /

IndustryTerm

niche product / non-animal injectable hyaluronic acid product / telephone book / treatment of osteoarthritis / chemical ingredients / sheet-metal workshop / /

Organization

Uppsala University in Sweden / U.S. Food and Drug Administration / Medical Faculty / University Hospital / FDA / Ophthalmics Division of Pharmacia / /

Person

Bengt Ågerup / Helen Ågerup / Arne Stenberg / Göran Läckgren / Karin Falck / /

Position

physiologist / poor chemist / Author / Senior Business Consultant / Director the Managing / Director of R&D / Managing Director / Manager of Clinical Research for eye surgery / nurse / physician / Director of Explorative Research / brief CEO and Founder / head / entrepreneur / the Manager of Clinical Research for eye surgery / founder / /

Product

Restylane Perlane™ / /

Technology

NASHA technology / NASHA™ technology / /

SocialTag